CTAP TFA
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-P1335A-10 mg |
| Pricing | 10 mg, USD $930.0 |
| Biological Activity | CTAP TFA is a potent, highly selective, and brain penetrant μ opioid receptor antagonist (IC50=3.5 nM) and displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP TFA can be used for the study of L-DOPA-induced dyskinesia (LID)[1]. |
| Purity | 99.48% |
| MWt | 1218.32 |
| Formula | C₅₃H₇₀F₃N₁₃O₁₂S₂ |